<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34401886</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2022</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>T cell responses to SARS-CoV-2 in people with and without neurologic symptoms of long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2021.08.08.21261763</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2021.08.08.21261763</ELocationID><Abstract><AbstractText>Many people experiencing long COVID syndrome, or post-acute sequelae of SARS-CoV-2 infection (PASC), suffer from debilitating neurologic symptoms (Neuro-PASC). However, whether virus-specific adaptive immunity is affected in Neuro-PASC patients remains poorly understood. We report that Neuro-PASC patients exhibit distinct immunological signatures composed of elevated humoral and cellular responses toward SARS-CoV-2 Nucleocapsid protein at an average of 6 months post-infection compared to healthy COVID convalescents. Neuro-PASC patients also had enhanced virus-specific production of IL-6 from and diminished activation of CD8<sup>+</sup> T cells. Furthermore, the severity of cognitive deficits or quality of life disturbances in Neuro-PASC patients were associated with a reduced diversity of effector molecule expression in T cells but elevated IFN-&#x3b3; production to the C-terminal domain of Nucleocapsid protein. Proteomics analysis showed enhanced plasma immunoregulatory proteins and reduced pro-inflammatory and antiviral response proteins in Neuro-PASC patients compared with healthy COVID convalescents, which were also correlated with worse neurocognitive dysfunction. These data provide new insight into the pathogenesis of long COVID syndrome and a framework for the rational design of predictive biomarkers and therapeutic interventions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Visvabharathy</LastName><ForeName>Lavanya</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago IL 60611 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanson</LastName><ForeName>Barbara A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago IL 60611 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orban</LastName><ForeName>Zachary S</ForeName><Initials>ZS</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago IL 60611 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Patrick H</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago IL 60611 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palacio</LastName><ForeName>Nicole M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago IL 60611 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimenez</LastName><ForeName>Millenia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago IL 60611 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Jeffrey R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago IL 60611 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graham</LastName><ForeName>Edith L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago IL 60611 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liotta</LastName><ForeName>Eric M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago IL 60611 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tachas</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Director, Drug Discovery &amp; Patents, Antisense Therapeutics Ltd., Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penaloza-MacMaster</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago IL 60611 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koralnik</LastName><ForeName>Igor J</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago IL 60611 USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>L30 NS098427</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DP2 DA051912</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 EB027049</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AR007611</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA060553</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 immunity</Keyword><Keyword MajorTopicYN="N">Neuro-PASC</Keyword><Keyword MajorTopicYN="N">T cell memory</Keyword><Keyword MajorTopicYN="N">immunoregulation</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">proteomics</Keyword></KeywordList><CoiStatement>Declaration of Interests The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>17</Day><Hour>7</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34401886</ArticleId><ArticleId IdType="pmc">PMC8366804</ArticleId><ArticleId IdType="doi">10.1101/2021.08.08.21261763</ArticleId><ArticleId IdType="pii">2021.08.08.21261763</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Center JCR. Cumulative worldwide Covid-19 cases. https://coronavirus.jhu.edu/map.html.
Accessed
October 5, 2022.</Citation></Reference><Reference><Citation>Syed A, et al. Gastrointestinal pathophysiology of SARS-CoV2 - a literature review. J Community Hosp Intern Med Perspect. 2020;10(6):523&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7599006</ArticleId><ArticleId IdType="pubmed">33194122</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori C, et al. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain Behav Immun. 2020;88:11&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7235586</ArticleId><ArticleId IdType="pubmed">32416289</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins V, et al. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci. 2020:1&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">33347790</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, et al. Persistent symptoms after Covid-19: qualitative study of 114 &#x201c;long Covid&#x201d; patients and draft quality principles for services. BMC Health Serv Res. 2020;20(1):1144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghimi N, et al. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection. Curr Neurol Neurosci Rep. 2021;21(9):44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8237541</ArticleId><ArticleId IdType="pubmed">34181102</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, et al. Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients. Clin Infect Dis. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H, et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. J Rehabil Med. 2020;52(5):jrm00063.</Citation><ArticleIdList><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, Trender W., Chamberlain SR, Jolly AE, Grant JE, Patrick F, Mazibuko N, Williams S, Barnaby JM, Hellyer H, Mehta MA. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Grifoni A, et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181(7):1489&#x2013;501 e15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7237901</ArticleId><ArticleId IdType="pubmed">32473127</ArticleId></ArticleIdList></Reference><Reference><Citation>Toor SM, et al. T-cell responses and therapies against SARS-CoV-2 infection. Immunology. 2021;162(1):30&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7730020</ArticleId><ArticleId IdType="pubmed">32935333</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan YQ, et al. Deficiency of Tfh Cells and Germinal Center in Deceased COVID-19 Patients. Curr Med Sci. 2020;40(4):618&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7412778</ArticleId><ArticleId IdType="pubmed">32767259</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahan K, et al. Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature. 2021;590(7847):630&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906955</ArticleId><ArticleId IdType="pubmed">33276369</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan YY, et al. Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection. Arch Virol. 2009;154(7):1093&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2796960</ArticleId><ArticleId IdType="pubmed">19526193</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann Clin Transl Neurol. 2021;8(5):1073&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang E, et al. Validation of the Patient-Reported Outcomes Measurement Information System (PROMIS)-57 and &#x2212;29 item short forms among kidney transplant recipients. Qual Life Res. 2019;28(3):815&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">30467780</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub S, et al. Cognition assessment using the NIH Toolbox. Neurology. 2013;80(11 Suppl 3):S54&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3662346</ArticleId><ArticleId IdType="pubmed">23479546</ArticleId></ArticleIdList></Reference><Reference><Citation>Dangi T, et al. Cross-protective immunity following coronavirus vaccination and coronavirus infection. J Clin Invest. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670840</ArticleId><ArticleId IdType="pubmed">34623973</ArticleId></ArticleIdList></Reference><Reference><Citation>Meckiff BJ, et al. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19. Cell. 2020;183(5):1340&#x2013;53 e16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534589</ArticleId><ArticleId IdType="pubmed">33096020</ArticleId></ArticleIdList></Reference><Reference><Citation>Sledzinska A, et al. Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4(+) T Cells. Immunity. 2020;52(1):151&#x2013;66 e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7369640</ArticleId><ArticleId IdType="pubmed">31924474</ArticleId></ArticleIdList></Reference><Reference><Citation>Sant AJ, et al. Distinct and complementary roles of CD4 T cells in protective immunity to influenza virus. Curr Opin Immunol. 2018;53:13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6141328</ArticleId><ArticleId IdType="pubmed">29621639</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Martinez A, et al. Cytotoxic CD4(+) T-cells during HIV infection: Targets or weapons? J Clin Virol. 2019;119:17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">31445411</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutsakos M, et al. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses. Cell Rep Med. 2021;2(3):100208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7862905</ArticleId><ArticleId IdType="pubmed">33564749</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, et al. Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals. J Immunol. 2005;175(1):591&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15972696</ArticleId></ArticleIdList></Reference><Reference><Citation>Velazquez-Salinas L, et al. The Role of Interleukin 6 During Viral Infections. Front Microbiol. 2019;10:1057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6524401</ArticleId><ArticleId IdType="pubmed">31134045</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyette LB, et al. Phenotype, function, and differentiation potential of human monocyte subsets. PLoS One. 2017;12(4):e0176460.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5406034</ArticleId><ArticleId IdType="pubmed">28445506</ArticleId></ArticleIdList></Reference><Reference><Citation>Meya DB, et al. Monocyte Phenotype and IFN-gamma-Inducible Cytokine Responses Are Associated with Cryptococcal Immune Reconstitution Inflammatory Syndrome. J Fungi (Basel). 2017;3(2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5715914</ArticleId><ArticleId IdType="pubmed">29371546</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao Z, et al. Proteomic study of hepatocellular carcinoma using a novel modified aptamer-based array (SOMAscan) platform. Biochim Biophys Acta Proteins Proteom. 2017;1865(4):434&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">27663888</ArticleId></ArticleIdList></Reference><Reference><Citation>Timsina J, et al. Comparative Analysis of Alzheimer&#x2019;s Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach. J Alzheimers Dis. 2022;89(1):193&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9562128</ArticleId><ArticleId IdType="pubmed">35871346</ArticleId></ArticleIdList></Reference><Reference><Citation>George MJ, et al. Novel Insights Into the Effects of Interleukin 6 Antagonism in Non-ST-Segment-Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform. J Am Heart Assoc. 2020;9(12):e015628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7429051</ArticleId><ArticleId IdType="pubmed">32515246</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold L, et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One. 2010;5(12):e15004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000457</ArticleId><ArticleId IdType="pubmed">21165148</ArticleId></ArticleIdList></Reference><Reference><Citation>Parolo S, et al. Combined use of protein biomarkers and network analysis unveils deregulated regulatory circuits in Duchenne muscular dystrophy. PLoS One. 2018;13(3):e0194225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5846794</ArticleId><ArticleId IdType="pubmed">29529088</ArticleId></ArticleIdList></Reference><Reference><Citation>Matkovic R, et al. TASOR epigenetic repressor cooperates with a CNOT1 RNA degradation pathway to repress HIV. Nat Commun. 2022;13(1):66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8748822</ArticleId><ArticleId IdType="pubmed">35013187</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschtick JL, et al. Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) prevalence and characteristics. Clin Infect Dis. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8240848</ArticleId><ArticleId IdType="pubmed">34007978</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, et al. Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers. JAMA. 2021;325(19):2015&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf D, et al. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome. Sci Immunol. 2020;5(48).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7319493</ArticleId><ArticleId IdType="pubmed">32591408</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekine T, et al. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19. Cell. 2020;183(1):158&#x2013;68 e14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7427556</ArticleId><ArticleId IdType="pubmed">32979941</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S, et al. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. 2018;16(1):268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingenstein M, et al. Evidence of SARS-CoV2 Entry Protein ACE2 in the Human Nose and Olfactory Bulb. Cells Tissues Organs. 2020;209(4&#x2013;6):155&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7900466</ArticleId><ArticleId IdType="pubmed">33486479</ArticleId></ArticleIdList></Reference><Reference><Citation>Dangi T, et al. Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2. Cell Rep. 2021;36(10):109664.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8367759</ArticleId><ArticleId IdType="pubmed">34450033</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantonen J, et al. Neuropathologic features of four autopsied COVID-19 patients. Brain Pathol. 2020;30(6):1012&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436498</ArticleId><ArticleId IdType="pubmed">32762083</ArticleId></ArticleIdList></Reference><Reference><Citation>Heming M, et al. Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid. Immunity. 2021;54(1):164&#x2013;75 e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7831653</ArticleId><ArticleId IdType="pubmed">33382973</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer F, et al. Cerebrospinal Fluid Analysis Post-COVID-19 Is Not Suggestive of Persistent Central Nervous System Infection. Ann Neurol. 2022;91(1):150&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8653324</ArticleId><ArticleId IdType="pubmed">34724243</ArticleId></ArticleIdList></Reference><Reference><Citation>Myasoedova E, et al. Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955&#x2013;2007. Arthritis Rheum. 2010;62(6):1576&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2929692</ArticleId><ArticleId IdType="pubmed">20191579</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, et al. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Boersma P, et al. Prevalence of Multiple Chronic Conditions Among US Adults, 2018. Prev Chronic Dis. 2020;17:E106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7553211</ArticleId><ArticleId IdType="pubmed">32945769</ArticleId></ArticleIdList></Reference><Reference><Citation>Alter G, et al. Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans. Nature. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8357629</ArticleId><ArticleId IdType="pubmed">34107529</ArticleId></ArticleIdList></Reference><Reference><Citation>Elyanow R, et al. T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibody titers and disease severity. medRxiv. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9220924</ArticleId><ArticleId IdType="pubmed">35439166</ArticleId></ArticleIdList></Reference><Reference><Citation>Good-Jacobson KL, and Shlomchik MJ. Plasticity and heterogeneity in the generation of memory B cells and long-lived plasma cells: the influence of germinal center interactions and dynamics. J Immunol. 2010;185(6):3117&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">20814029</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumjohann D, et al. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity. 2013;38(3):596&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pubmed">23499493</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Elslande J, et al. Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection. J Clin Virol. 2021;136:104765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7891078</ArticleId><ArticleId IdType="pubmed">33636554</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan JT, et al. 4&#x2013;1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J Immunol. 1999;163(9):4859&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">10528187</ArticleId></ArticleIdList></Reference><Reference><Citation>Derhovanessian E, et al. Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans. J Gen Virol. 2011;92(Pt 12):2746&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">21813708</ArticleId></ArticleIdList></Reference><Reference><Citation>Strutt TM, et al. Direct IL-6 Signals Maximize Protective Secondary CD4 T Cell Responses against Influenza. J Immunol. 2016;197(8):3260&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5101150</ArticleId><ArticleId IdType="pubmed">27647834</ArticleId></ArticleIdList></Reference><Reference><Citation>Diehl S, et al. Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity. 2000;13(6):805&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">11163196</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R, and Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39(5):529&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7079893</ArticleId><ArticleId IdType="pubmed">28466096</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W, et al. TLR ligand induced IL-6 counter-regulates the anti-viral CD8(+) T cell response during an acute retrovirus infection. Sci Rep. 2015;5:10501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4440206</ArticleId><ArticleId IdType="pubmed">25994622</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin H, et al. Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection. J Exp Med. 2007;204(4):941&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2118542</ArticleId><ArticleId IdType="pubmed">17420267</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnstorf I, et al. Chronic virus infection compromises memory bystander T cell function in an IL-6/STAT1-dependent manner. J Exp Med. 2019;216(3):571&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6400541</ArticleId><ArticleId IdType="pubmed">30745322</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen SF, et al. Increased pain sensitivity and decreased opioid analgesia in T-cell-deficient mice and implications for sex differences. Pain. 2019;160(2):358&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">30335680</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, et al. Transcriptomic profiling of peripheral blood CD4(+) T-cells in asthmatics with and without depression. Gene. 2015;565(2):282&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">25871513</ArticleId></ArticleIdList></Reference><Reference><Citation>Garber C, et al. T cells promote microglia-mediated synaptic elimination and cognitive dysfunction during recovery from neuropathogenic flaviviruses. Nat Neurosci. 2019;22(8):1276&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6822175</ArticleId><ArticleId IdType="pubmed">31235930</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark MC, and Stein A. CD33 directed bispecific antibodies in acute myeloid leukemia. Best Pract Res Clin Haematol. 2020;33(4):101224.</Citation><ArticleIdList><ArticleId IdType="pubmed">33279180</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallmer K, et al. NK cells negatively regulate CD8 T cells via natural cytotoxicity receptor (NCR) 1 during LCMV infection. PLoS Pathog. 2019;15(4):e1007725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6469806</ArticleId><ArticleId IdType="pubmed">30995287</ArticleId></ArticleIdList></Reference><Reference><Citation>Correale J, and Villa A. Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis. J Neuroimmunol. 2008;195(1&#x2013;2):121&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">18234356</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JH, et al. Calcineurin-dependent negative regulation of CD94/NKG2A expression on naive CD8+ T cells. Blood. 2011;118(1):116&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">21540458</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M, et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17(5):533&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7091858</ArticleId><ArticleId IdType="pubmed">32203188</ArticleId></ArticleIdList></Reference><Reference><Citation>Palacio N, et al. Early type I IFN blockade improves the efficacy of viral vaccines. J Exp Med. 2020;217(12).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7953731</ArticleId><ArticleId IdType="pubmed">32820330</ArticleId></ArticleIdList></Reference><Reference><Citation>Roederer M, et al. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A. 2011;79(2):167&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3072288</ArticleId><ArticleId IdType="pubmed">21265010</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>